Page last updated: 2024-08-24

triazoles and ganciclovir

triazoles has been researched along with ganciclovir in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chen, MH; Crespo, M; Humar, A; Husain, S; Kumar, D; Manuel, O; McCurry, KR; Moussa, G; Pilewski, J; Studer, SM1
Karaahmet, T; Korten, V; Odabasi, Z; Tigen, E; Tigen, K1
Bermudez, C; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A1
Andrei, G; Chen, X; Liu, NN; Schols, D; Snoeck, R; Wen, YN; Wu, QP; Xiang, YH; Zhang, QS; Zhang, ZF; Zhang, ZY1
Celegato, M; Gribaudo, G; Lepesheva, GI; Loregian, A; Luganini, A; Mercorelli, B; Palù, G1

Other Studies

5 other study(ies) available for triazoles and ganciclovir

ArticleYear
Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis.
    Transplantation, 2009, Mar-15, Volume: 87, Issue:5

    Topics: Adult; Antifungal Agents; Antiviral Agents; Bronchiolitis Obliterans; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Graft Rejection; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Pyrimidines; Syndrome; Triazoles; Valganciclovir; Voriconazole

2009
Concomitant Aspergillus and Cytomegalovirus infection in heart transplant: early diagnosis is the key to successful treatment.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2009, Volume: 7, Issue:3

    Topics: Acute Disease; Antifungal Agents; Antiviral Agents; Cardiomyopathy, Dilated; Cytomegalovirus Infections; Early Diagnosis; Ganciclovir; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Opportunistic Infections; Pulse Therapy, Drug; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2009
Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2010, Volume: 29, Issue:9

    Topics: Acute Disease; Adolescent; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antiviral Agents; Cytomegalovirus Infections; Female; Follow-Up Studies; Ganciclovir; Graft Rejection; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Pyrimidines; Reoperation; Retrospective Studies; Survivors; Time Factors; Tissue Donors; Triazoles; Valganciclovir; Voriconazole

2010
Synthesis and Ativiral Activity of 5-(Benzylthio)-4-carbamyl-1,2,3-triazoles Against Human Cytomegalovirus (CMV) and Varicella-zoster Virus (VZV).
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2017, Volume: 13, Issue:5

    Topics: Acyclovir; Antiviral Agents; Bromodeoxyuridine; Cidofovir; Cytomegalovirus; Cytosine; Ganciclovir; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 3, Human; Organophosphonates; Thymidine Kinase; Triazoles

2017
The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication.
    Antimicrobial agents and chemotherapy, 2020, 09-21, Volume: 64, Issue:10

    Topics: Antifungal Agents; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Pharmaceutical Preparations; Triazoles; Virus Replication

2020